PARTNER 3 Trial - Mitral Valve in Valve
PARTNER 3 Trial - SAPIEN 3 Transcatheter Heart Valve Implantation in Patients With a Failing Mitral Bioprosthetic Valve
Sponsor: Edwards Lifesciences
A NA clinical study on Heart Failure and Mitral Valve Disease, this trial is ongoing. The trial is conducted by Edwards Lifesciences and has accumulated 18 data snapshots since 2018. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
18 versions recorded-
Dec 2025 — Present [monthly]
Active Not Recruiting NA
-
Sep 2025 — Dec 2025 [monthly]
Active Not Recruiting NA
-
Nov 2024 — Sep 2025 [monthly]
Active Not Recruiting NA
-
Sep 2024 — Nov 2024 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
▶ Show 13 earlier versions
-
Nov 2023 — Jul 2024 [monthly]
Active Not Recruiting NA
-
Nov 2022 — Nov 2023 [monthly]
Active Not Recruiting NA
-
Oct 2021 — Nov 2022 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2021 — Oct 2021 [monthly]
Recruiting NA
-
Jan 2021 — Sep 2021 [monthly]
Recruiting NA
-
Nov 2020 — Jan 2021 [monthly]
Recruiting NA
-
Mar 2020 — Nov 2020 [monthly]
Recruiting NA
-
Feb 2020 — Mar 2020 [monthly]
Recruiting NA
-
Feb 2019 — Feb 2020 [monthly]
Recruiting NA
-
Nov 2018 — Feb 2019 [monthly]
Recruiting NA
-
Jun 2018 — Nov 2018 [monthly]
Recruiting NA
-
May 2018 — Jun 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jul 2017 — May 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Edwards Lifesciences
For direct contact, visit the study record on ClinicalTrials.gov .